68 related articles for article (PubMed ID: 1517566)
1. Locus-specific transcriptional control of HLA genes.
Soong TW; Hui KM
J Immunol; 1992 Sep; 149(6):2008-20. PubMed ID: 1517566
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element.
Gobin SJ; van Zutphen M; Woltman AM; van den Elsen PJ
J Immunol; 1999 Aug; 163(3):1428-34. PubMed ID: 10415043
[TBL] [Abstract][Full Text] [Related]
3. The regulatory complex of HLA class I promoters exhibits locus-specific conservation with limited allelic variation.
Cereb N; Yang SY
J Immunol; 1994 Apr; 152(8):3873-83. PubMed ID: 8144957
[TBL] [Abstract][Full Text] [Related]
4. Regulation of MHC class I and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes.
Drew PD; Lonergan M; Goldstein ME; Lampson LA; Ozato K; McFarlin DE
J Immunol; 1993 Apr; 150(8 Pt 1):3300-10. PubMed ID: 8468472
[TBL] [Abstract][Full Text] [Related]
5. A novel DNA binding activity is elevated in thymocytes expressing high levels of H-2Dd after radiation leukemia virus infection.
Nobunaga T; Brown GD; Morris DR; Meruelo D
J Immunol; 1992 Aug; 149(3):871-9. PubMed ID: 1634776
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the expression of major histocompatibility complex class I genes in human colorectal cancer.
Soong TW; Hui KM
Cancer Detect Prev; 1991; 15(3):231-9. PubMed ID: 1905582
[TBL] [Abstract][Full Text] [Related]
7. The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B.
Gobin SJ; Keijsers V; van Zutphen M; van den Elsen PJ
J Immunol; 1998 Sep; 161(5):2276-83. PubMed ID: 9725221
[TBL] [Abstract][Full Text] [Related]
8. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines.
Marincola FM; Shamamian P; Alexander RB; Gnarra JR; Turetskaya RL; Nedospasov SA; Simonis TB; Taubenberger JK; Yannelli J; Mixon A
J Immunol; 1994 Aug; 153(3):1225-37. PubMed ID: 8027550
[TBL] [Abstract][Full Text] [Related]
9. Identification of locus-specific DNA-binding factors for the regulation of HLA class-I genes in human colorectal cancer.
Soong TW; Hui KM
Int J Cancer Suppl; 1991; 6():131-7. PubMed ID: 2066178
[TBL] [Abstract][Full Text] [Related]
10. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene.
Christensen SM; Martin BK; Tan SS; Weis JH
J Immunol; 1992 Jun; 148(11):3610-7. PubMed ID: 1534100
[TBL] [Abstract][Full Text] [Related]
11. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
Park SH; Kim YS; Park BK; Hougaard S; Kim SJ
Oncogene; 2001 Mar; 20(10):1235-45. PubMed ID: 11313868
[TBL] [Abstract][Full Text] [Related]
12. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
[TBL] [Abstract][Full Text] [Related]
13. Site-specific mutagenesis of the class I regulatory element the Q10 gene allows expression in non-liver tissues.
Handy DE; Burke PA; Ozato K; Coligan JE
J Immunol; 1989 Feb; 142(3):1015-21. PubMed ID: 2913151
[TBL] [Abstract][Full Text] [Related]
14. The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human alpha-folate receptor gene in ovarian carcinoma.
Tomassetti A; Mangiarotti F; Mazzi M; Sforzini S; Miotti S; Galmozzi E; Elwood PC; Canevari S
Cancer Res; 2003 Feb; 63(3):696-704. PubMed ID: 12566316
[TBL] [Abstract][Full Text] [Related]
15. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
Redondo M; Ruiz-Cabello F; Concha A; Cabrera T; Pérez-Ayala M; Oliva MR; Garrido F
Cancer Res; 1991 May; 51(9):2463-8. PubMed ID: 1849792
[TBL] [Abstract][Full Text] [Related]
16. Differential expression and interferon response of HLA class I genes in thymocyte lines and response variants.
Girdlestone J; Milstein C
Eur J Immunol; 1988 Jan; 18(1):139-43. PubMed ID: 2450029
[TBL] [Abstract][Full Text] [Related]
17. HLA-E is the only class I gene that escapes CpG methylation and is transcriptionally active in the trophoblast-derived human cell line JAR.
Boucraut J; Guillaudeux T; Alizadeh M; Boretto J; Chimini G; Malecaze F; Semana G; Fauchet R; Pontarotti P; Le Bouteiller P
Immunogenetics; 1993; 38(2):117-30. PubMed ID: 7683306
[TBL] [Abstract][Full Text] [Related]
18. Role of the interferon-stimulated response element in HLA-B downregulation in human melanoma cell lines.
Griffioen M; Ouwerkerk IJ; Harten V; Gobin SJ; van den Elsen PJ; Schrier PI
Immunogenetics; 1999 Apr; 49(4):287-94. PubMed ID: 10079292
[TBL] [Abstract][Full Text] [Related]
19. HLA-B locus-specific downregulation in human melanoma requires enhancer A as well as a sequence element located downstream of the transcription initiation site.
Griffioen M; Ouwerkerk IJ; Harten V; Schrier PI
Immunogenetics; 2000 Nov; 52(1-2):121-8. PubMed ID: 11132148
[TBL] [Abstract][Full Text] [Related]
20. Nuclear protein binding patterns in the 5'-upstream regulatory elements of HLA class I genes.
Park JH; Kim JD; Kim SJ
Yonsei Med J; 1994 Sep; 35(3):295-307. PubMed ID: 7975738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
